Comanche County Medical Center (CCMC), a nonprofit hospital and rural health organization based in Comanche, Texas, has an innovative diabetes infusion program that is getting a lot of attention.

The Texas Organization of Rural and Community Hospitals (TORCH) statewide conference April 19-21 will feature the program. Led by CEO Larry Troxell, DHA, and clinical director Dwayne C. Miller, MD, the physician-prescribed treatment, which started up last summer at CCMC, is seeing patients from all corners of Texas. The hospital is the only one of its kind in the U.S. offering the infusion, which goes by the commercial name Diabetes Relief™.

The treatment addresses the root causes of diabetes and other metabolic disorders by decreasing insulin resistance and inflammation. Insulin is administered in a way that bio mimics insulin’s release as a hormone rather than a drug. This helps blood sugar more readily enter the cells and convert to energy. The increase in cellular energy allows damaged tissues and organs to repair and grow. The treatment also includes dietary and lifestyle support provided by a patient’s care team.

“We have seen improvements in neuropathy, retinopathy, and Parkinson’s symptoms, among others, and we’ve helped patients with diabetes to avoid dialysis” says Troxell.

One participating CCMC patient with age-related macular degeneration has improved eyesight under the Diabetes Relief™ program. With continuing results like this, it is no surprise that people are seeking out the CCMC program. Troxell is heading up a study on the outcomes of the CCMC infusion program as part of his postdoctoral research with his alma mater, Medical University of South Carolina. It includes collecting patient data, building a database, tracking outcomes, and in-depth analyses. Data of over 100 patients is included in the study thus far, and hundreds more are anticipated. The results of the study will contribute to the increasing number of evidence-based published works on Physiologic Insulin Resensitization (PIR).

Last week, John Henderson, who leads TORCH, observed the Diabetes Relief™ treatment at work in the Comanche hospital. Troxell and other CCMC staff will be attending the TORCH statewide conference in Dallas in April to share with attendees their experience with the infusion program.